For perimenopause and menopause Up to 85% of women experience menopause-related symptoms, including weight redistribution, fatigue, mood changes, and joint pain
tirzepatide is technically a dual GIP and GLP-1 receptor agonist) after a Stage I to III obesity-related cancer diagnosis, comparing them with patients who started a DPP-4 inhibitor instead
Additionally, in response to a meal, in patients with short bowel syndrome with a preserved colon (jejuno-colonic anastomosis), both baseline GLP-1 and GLP-2 are elevated with GLP-2 levels threefold greater than control patients (average concentration of 72 pmol/L), which persists throughout the post-prandial period (Jeppesen et al., 2000)
Cerovecki T, Bojanic I, Brcic L, et al